✦ LIBER ✦

UP-02.062 Clinical, Biochemical and Radiologic Benefit of the Treatment with Sunitinib in Monotherapy for Patients with Metastatic Castration-Resistant Prostate Cancer After Failure of Docetaxel

✍ Scribed by C. Casu; A. Rodriguez Antolin; D. Castellano; L. Anton Aparicio; J. Romero Otero; L. Díez Sicilia; F. Guerrero Ramos; J. Almonacid Grunert; R. Díaz Gonzalez

Book ID: 116954722
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 79 KB
Volume: 78
Category: Article
ISSN: 0090-4295
DOI: 10.1016/j.urology.2011.07.880

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized phase II study of danusertib

Randomized phase II study of danusertib in patients with metastatic castration-resistant prostate cancer after docetaxel failure

✍ Hielke J. Meulenbeld; Jean P. Bleuse; Elio M. Vinci; Eric Raymond; Giordano Vita 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB

1090 CLINICAL BENEFIT OF CABAZITAXEL PLU

1090 CLINICAL BENEFIT OF CABAZITAXEL PLUS PREDNISONE IN THE TROPIC TRIAL IN MEN WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER (MCRPC) WHO PROGRESSED AFTER DOCETAXEL-BASED TREATMENT

✍ Tombal, B.; Oudard, S.; Ozguroglu, M.; Hansen, S.; Kocak, I.; Gravis, G.; Sartor 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 262 KB

954 THE ADDITION OF ESTRAMUSTINE TO PRED

954 THE ADDITION OF ESTRAMUSTINE TO PREDNISONE/DOCETAXEL FOR PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER AFTER P/D FAILURE: A SINGLE-CENTER EXPERIENCE

✍ Sun, Zhong-Quan 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 52 KB

7061 POSTER Assessment of Bone Remodelin

7061 POSTER Assessment of Bone Remodeling Markers and Their Relevance as Prognostic Factors for Overall Survival (OS) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Patients (Pts) Treated With Sunitinib (S) After Docetaxel Failure – a Prospective Study

✍ Maruani, G.M.; Elaidi, E.R.; Gachet, J.G.; Kempf, E.K.; Brizard, M.B.; Banu, E.B 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Aflibercept versus placebo in combinatio

Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial

✍ Tannock, Ian F; Fizazi, Karim; Ivanov, Sergey; Karlsson, Camilla Thellenberg; Fl 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 310 KB

Effects of androgen deprivation therapy

Effects of androgen deprivation therapy and bisphosphonate treatment on bone in patients with metastatic castration-resistant prostate cancer: Results from the University of Washington Rapid Autopsy Series

✍ Morrissey, Colm; Roudier, Martine P; Dowell, Alex; True, Lawrence D; Ketchanji, 📂 Article 📅 2013 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 516 KB